2013 – PCI acquired AndersonBrecon, Inc.
2014 – PCI acquired Penn Pharma and Biotec Services
Number of Employees: 3,000
Key Personnel: Bill Mitchell, CEO and President; Bill Bolding,
Chief Operating Officer; Mitch Blumenfeld, Chief Financial
Officer; Richard Yarwood, Sr. VP International; Phil DiGiacomo,
Sr. VP Sales & Marketing; Robert Misher, Sr. VP Global Clinical
Services; Jeannie Metzinger, Vice President – Quality
PCI Pharma Services is an integrated full service provider, a proven
and trusted partner to leading companies in the global healthcare
industry. We offer unparalleled expertise and experience in taking
compounds from the earliest stages of development through to
successful commercialization, delivering speed-to-market and
commercial success for our customers.
Our core services support each stage of the product lifecycle,
including drug development, clinical trial supply, commercial
launch and ongoing commercial supply. We partner with clients
in providing innovative technologies, flexible solutions, and
an integrated supply network supporting lifesaving medicines
destined to over 100 countries around the world.
We support clients with a dedication to providing the industry’s
leading experience, exemplified in our operational flexibility,
delivery, commitment to safety, supported by industry leading
technologies and an exemplary quality and regulatory record.
This has allowed us to be the partner of choice for leading
pharmaceutical companies around the world, operating as a
seamless extension of their business.
PCI provides Drug development, Clinical trial services, as well
as Commercial manufacturing and packaging services for brand
and generic pharmaceuticals, biotech, device, over-the-counter
pharmaceuticals, animal health, and consumer healthcare/beauty.
Our state-of-the-art cGMP facilities feature site segregation for
Schedule II – V Controlled Substances, Animal Health, Hormonal
Products, Penicillin Products, Cytotoxins, and Potent Compounds.
We support Cold Chain requirements including controlled ambient /
CRT: 15-25°C, 2-8°C, -20ºC, - 40°C, -80ºC, and - 196°C for Advanced
Therapeutic Medicinal Products (ATMP).
PCI offers full service Formulation Development including
Analytical Development/Characterization and Xcelodose
product-in-capsule delivery for early phase clinical trials.
Clinical Trial Services:
PCI supports investigational medicines with Tablet, Capsule,
Powder and Liquids Manufacturing, Analytical Development,
Stability Testing, Clinical Packaging and Labeling including
product Blinding and Randomization, Global Storage and
Distribution, as well as Returns Management and Destruction.
PCI supports commercial product manufacturing including
Commercial scale-up and large-scale manufacturing, including
installation of a new Gerteis roller compaction unit. We offer
Packaging Services for a broad range of delivery forms including Oral
Solids, Powders, Liquids, Creams, and Gels, as well as Injectable and
Parenteral Delivery forms including Device Assembly. In support of
commercial supply we offer Analytical Testing and Stability services.
PCI is Serialization ready, having invested in leading technologies
and providing commercial serialized product for over five
years supporting medicines destined to established and emerging
PCI provides manufacturing and packaging services for clinical and
commercial medicines. PCI features a state-of-the-art, purpose-built, contained manufacturing site for potent compounds with
OEL’s down to 0.01μg/m3. This facility was recognized by ISPE
as a Facility of the Year in 2013. Potent compound manufacturing
is further supported by segregated, purpose-built packaging
facilities in both Europe and North America.
3001 Red Lion Road
Philadelphia, PA 19114
Tel: +1 215-613-3600